Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.

Clinical trial NCT01991197 · COMPLETED

Trial details

NCT number: NCT01991197
Sponsor: University College Dublin
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Type 2 Diabetes Mellitus

Start date: 2014-04-01
Primary completion: 2016-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.